88 related articles for article (PubMed ID: 274177)
1. Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3.
Laszlo J; Fyfe MJ; Swedwick D; Lee L; Brown O
Cancer Treat Rep; 1978 Mar; 62(3):341-4. PubMed ID: 274177
[TBL] [Abstract][Full Text] [Related]
2. Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.
Fyfe MJ; Sedwick WD; Brown OE; Laszlo J
J Natl Cancer Inst; 1981 Mar; 66(3):445-51. PubMed ID: 6937701
[TBL] [Abstract][Full Text] [Related]
3. New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Sedwick WD; Kutler M; Frazer T; Brown OE; Laszlo J
Cancer Res; 1979 Sep; 39(9):3612-8. PubMed ID: 314333
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the lipid-soluble diaminopyrimidines, metoprine and etoprine, in the avian sarcoma virus rat glioma model.
Serano RD; Sigel CW; Nichol CA; Bigner DD
Cancer Treat Rep; 1982 Jan; 66(1):99-106. PubMed ID: 6272992
[TBL] [Abstract][Full Text] [Related]
5. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA: inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells.
Sedwick WD; Kutler M; Brown OE
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):917-21. PubMed ID: 6940156
[TBL] [Abstract][Full Text] [Related]
6. Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
Sedwick WD; Fyfe MJ; Brown OE; Frazer TA; Kutler M; Laszlo J
Mol Pharmacol; 1979 Sep; 16(2):607-13. PubMed ID: 514260
[No Abstract] [Full Text] [Related]
7. DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
Wilmanns W
Natl Cancer Inst Monogr; 1971 Dec; 34():153-9. PubMed ID: 5291099
[No Abstract] [Full Text] [Related]
8. Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
Sedwick WD; Fyfe MJ; Hamrell M; Laszlo J
Adv Enzyme Regul; 1978; 17():399-416. PubMed ID: 294129
[No Abstract] [Full Text] [Related]
9. Enzyme activities and deoxynucleoside utilization of leukemic leukocytes in relation to drug therapy and resistance.
Roberts D; Hall TC
Cancer Res; 1969 Jan; 29(1):166-73. PubMed ID: 5249740
[No Abstract] [Full Text] [Related]
10. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells.
Chitnis M; Juvekar A; Adwankar M; Advani S
Anticancer Res; 1986; 6(4):749-51. PubMed ID: 3463243
[TBL] [Abstract][Full Text] [Related]
11. Natural resistance to methotrexate in human acute nonlymphocytic leukemia.
Bertino JR; Sawicki WL; Cashmore AR; Cadman EC; Skeel RT
Cancer Treat Rep; 1977 Jul; 61(4):667-73. PubMed ID: 267508
[No Abstract] [Full Text] [Related]
12. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
Chabner BA; Young RC
J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
[TBL] [Abstract][Full Text] [Related]
13. The intracellular mechanism of action of metoprine (DDMP).
Browman GP; Calvert AH; Taylor GA; Hart LI; Harrap KR
Eur J Cancer (1965); 1980 Dec; 16(12):1547-54. PubMed ID: 6971755
[No Abstract] [Full Text] [Related]
14. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
Galivan J; Nimec Z; Rhee M
Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
[TBL] [Abstract][Full Text] [Related]
15. Lipid-soluble inhibitors of dihydrofolate reductase. I. Kinetics, tissue distribution, and extent of metabolism of pyrimethamine, metoprine, and etoprine in the rat, dog, and man.
Cavallito JC; Nichol CA; Brenckman WD; Deangelis RL; Stickney DR; Simmons WS; Sigel CW
Drug Metab Dispos; 1978; 6(3):329-37. PubMed ID: 26555
[TBL] [Abstract][Full Text] [Related]
16. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells.
Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP
Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205
[No Abstract] [Full Text] [Related]
17. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
Creasey WA; DeConti RC; Kaplan SR
Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
[No Abstract] [Full Text] [Related]
18. Deoxyribonucleoside triphosphate metabolism of leukemic cells.
Omine M; Iwata N; Arai T; Suda T
Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):1092-103. PubMed ID: 273360
[No Abstract] [Full Text] [Related]
19. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
Roberts D; Franklin P; Odom G; Peck C; Chwang TL
Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
